PT Kalbe Farma Tbk. (IDX:KLBF)

Indonesia flag Indonesia · Delayed Price · Currency is IDR
1,105.00
-15.00 (-1.34%)
At close: Feb 9, 2026
Market Cap50.75T -19.1%
Revenue (ttm)34.38T +7.0%
Net Income3.49T +13.4%
EPS76.64 +14.7%
Shares Out45.32B
PE Ratio14.61
Forward PE13.78
Dividend36.00 (3.21%)
Ex-Dividend DateJun 4, 2025
Volume33,061,100
Average Volume59,541,710
Open1,130.00
Previous Close1,120.00
Day's Range1,090.00 - 1,130.00
52-Week Range985.00 - 1,600.00
Beta0.00
RSI38.70
Earnings DateMar 27, 2026

About PT Kalbe Farma Tbk.

PT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia. The company operates through Prescription Pharmaceuticals; Consumer Health; Nutritionals; and Distribution and Logistic segments. The company provides prescription/ethical; consumer health; nutritionals; distribution and logistics; health services; medical devices; biopharma; animal health; international business; and E-health products. It operates Mitrasana Clinics, a health care service. In addition, the company pro... [Read more]

Sector Healthcare
Founded 1966
Employees 12,784
Stock Exchange Indonesia Stock Exchange
Ticker Symbol KLBF
Full Company Profile

Financial Performance

In 2024, PT Kalbe Farma Tbk.'s revenue was 32.63 trillion, an increase of 7.16% compared to the previous year's 30.45 trillion. Earnings were 3.24 trillion, an increase of 17.13%.

Financial Statements